Dangerous Drugs
A personal injury lawyer from VanDerGinst Law, P.C. knows what encompasses drug litigation, drug lawsuits, drug side effects or any and all things pertaining to drugs injuring those who use them for medical treatment. While drugs are often tested ad nauseum to ensure they are safe for consumption by the public, dangerous drugs sometimes make their way to the public market. When a drug you use or haved used in the past is placed under a drug recall or a is suspended from sale pending further investigation, your first call should be to an educated and experienced drug lawyer.
Side effects are common knowledge in regards to modern drugs. So long as the health of the patient is advanced further by the use of the drug than it is adversely affected by its side effects, a drug will remain in use and on the free market. However, despite rigorous testing and regulation, drugs sometimes cause dangerous side effects after their introduction to market and patients can be left unaware of potential dangers.
When a drug causes dangerous side effects, including illness and death, the drug company responsible for the drug's manufacture is liable for any damages caused to patients who suffered from any undocumented risk of harm stemming from the drug treatment. In addition, medical professionals who prescribed the drug may also share liability under certain circumstances.
Mass torts is the term used to refer to pending litigation against the manufacturer of a dangerous drug. The Food and Drug Administration (FDA) regulates the pharmaceutical industry and issues numerous warnings and recalls regarding the safety of drugs every year. Despite the FDA's efforts to protect the consumer, dangerous drugs are still on the market and can result in serious injury or death of the patient. Mass torts are meant to provide people injured by dangerous drugs the ability to seek compensation through the legal system.
By law, drug manufacturers are responsible for injuries incurred by the patient if the product they sell is defective or unreasonably dangerous. A mass tort law firm is dedicated to serving the people who have been injured by dangerous drugs by holding drug manufacturers accountable for their products. Unfortunately, some drugs are still marketed by drug companies even after evidence of serious side effects or death had been noted.
The sale and marketing of dangerous drugs can happen in several ways. For example, the consumer may not be warned of potential serious side effects, the manufacturing process may be flawed, or the product itself may be defective. In all these cases, the manufacturer is liable and can be sued for damages even if they were unaware of the danger. It does not matter how carefully the product was produced or labeled.
Our comprehensive library of drug information serves as a resource to patients across the country who may have suffered as the result of dangerous drug side effects.
If you or a loved one has suffered an injury, illness or death after exposure to a dangerous pharmaceutical, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.
Dangerous Drugs
More Information
| Related Links
|
Links on the Web
 Food and Drug Administration--RecallsRecall information from FDA |
| Sun, 16 Mar 2008 15:42:00 GMT Publix Issues Recall for Assorted Flavors of Empanadas (March 14) Publix Super Markets is issuing a voluntary recall on all codes of prepackaged 2 and 4-pack Apple, Pineapple and Pumpkin Empanadas sold in retail bakeries due to the undeclared milk ingredient. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these products. Click here to read this Dangerous Drugs news article. |
| Fri, 14 Mar 2008 17:48:00 GMT Slade Gorton and Co. Recalls Icybay Cooked Langostinos Because of Possible Health Risk (March 14) The product retails in one pound, clear plastic package marked with UPC 0-73129-61672-8 on the top and with an expiration date of June 2009 and is distributed under the brand name of "ICYBAY". The product also was distributed to wholesale accounts, also under the "ICYBAY" brand, in five pound clear plastic packages containing either 70-90 count, 90-125 count or 120-150 count. This recall involves production dates of July 18, 2007 through August 13, 2007 and/or Julian dates of 199 through 232. Click here to read this Dangerous Drugs news article. |
| Mon, 10 Mar 2008 21:58:00 GMT Alaz Fine Food Corp. Issues Alert on Undeclared Sulfites in Delta Brand Golden Raisins (March 6) ALAZ FINE FOOD CORP is recalling Delta brand Golden Raisins because it contains undeclared sulfites. People who have severe sensitivity to sulfites run the risk of serious or life-threatening reactions if they consume this product. Click here to read this Dangerous Drugs news article. |
| Mon, 10 Mar 2008 12:43:00 GMT The Hartz Mountain Corporation Recalls Vitamin Care for Cats Because of Possible Health Risk (March 7) The Hartz Mountain Corporation is voluntarily recalling a second specific lot of Hartz Vitamin Care for Cats due to concerns that bottles within the lot may have been potentially contaminated with Salmonella. Hartz is fully cooperating with the US Food and Drug Administration in this voluntary recall. Hartz recalled a specific lot code of Hartz Vitamin Care for Cats last November due to similar concerns. Both lot codes were manufactured for Hartz by UFAC (USA) Inc. in 2007, and were removed from distribution last November. However, bottles from the second lot had been shipped to customers prior to their having been removed from distribution. Click here to read this Dangerous Drugs news article. |
| Sat, 08 Mar 2008 13:44:00 GMT Algae Bloom Prompts DSHS to Close 3 Bays to Shellfish Harvesting, Issue Recall (March 7) The Texas Department of State Health Services (DSHS) has closed Aransas, Corpus Christi and Copano bays to shellfish harvesting and has issued a recall of oysters, clams and mussels because of an algae bloom. DSHS officials say high concentrations of the Dinophysis organism have been found in several locations in the area. The toxin produced by this algae bloom, okadaic acid, can accumulate in shellfish tissue and cause diarrhetic shellfish poisoning, or DSP, in people who consume oysters, clams or mussels. Cooking does not destroy the toxin. Click here to read this Dangerous Drugs news article. |
| Wed, 05 Mar 2008 14:42:00 GMT New BCN Trading Inc. Issues Allergy Alert on Undeclared Sulfites in Asian Boy Sweet Ginger (Feb. 11) New BCN Trading Inc. of South Plainfield, NJ is recalling 7 oz. plastic tubs of Asian Boy Brand Dried Ginger because the product contains undeclared sulfites. Consumers who have severe sensitivity to sulfites run the risk of serious or life threatening allergic reactions if they consume this product. No illnesses have been reported to date in connection with this product. The Asian Boy Brand Dried Ginger, a product of Vietnam, was distributed to retail stores in NJ, NY, FL, MD, VA, CT, MA, OH and PA in an uncoded 7 oz. plastic tub. Click here to read this Dangerous Drugs news article. |
| Medical Devices / Diagnostics News From Medical News Today Latest Health News and Medical News posted throughout the day, every day. |
| Wed, 10 Mar 2010 03:00:00 PST Also In Global Health News: Leishmaniasis Treatment; China's National Health Plan; Zimbabwe Food Security; HIV/AIDS Spending In India Heating Device Effectively Treats Cutaneous Leishmaniasis, Study Says "A heating device that uses radio frequency energy to heat parasites and kill them could provide a new way to treat ... cutaneous leishmaniasis in Iraq, Afghanistan and elsewhere, military researchers reported Monday," the Los Angeles Times' blog "Booster Shots" reports... Click here to read this Dangerous Drugs news article. |
| Wed, 10 Mar 2010 01:00:00 PST Elevated Levels Of Cobalt And Chromium Found In Offspring Of Moms With Metal-on-Metal Hip Implants Women with metal-on-metal hip implants, where both the ball of the joint and the surface of the socket are made of metal, pass metal ions to their offspring during pregnancy, according to a study by researchers at Rush University Medical Center. The ions are the result of wear and corrosion as the metal parts rub against one another... Click here to read this Dangerous Drugs news article. |
| Tue, 09 Mar 2010 06:00:00 PST Carnegie Mellon Initiative To Commercialize Quality Of Life Technologies Boosted By NSF Grant An already promising initiative to assist start-up firms that commercialize technologies associated with the Quality of Life Technology (QoLT) Center is now expanding thanks to a three-year, $1.5 million Innovation Award from the National Science Foundation's (NSF) Division of Engineering Education and Centers... Click here to read this Dangerous Drugs news article. |
| Tue, 09 Mar 2010 01:00:00 PST NxStage Announces New FREEDOM Data Showing The Positive Impact Of Its Daily Home Hemodialysis Therapy On Sleep Quality And Restless Legs Syndrome Booths # 23-25 at the Annual Dialysis Conference -- NxStage Medical, Inc... Click here to read this Dangerous Drugs news article. |
| Tue, 09 Mar 2010 01:00:00 PST Axis Surgical Technologies, Inc. Received 510(k) Clearance For The C-MOR(TM) Visualization Device Axis Surgical Technologies, Inc., announced that it has received 510(k) clearance from the Food and Drug Administration to market their C-MOR? Visualization Device for use in diagnostic and operative arthroscopic and endoscopic procedures... Click here to read this Dangerous Drugs news article. |
| Tue, 09 Mar 2010 01:00:00 PST FDA Clears The Fenwal Amicus(R) Separator System For Collecting Platelets In New Additive Solution Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3)... Click here to read this Dangerous Drugs news article. |
